Terms: = Pancreatic cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Prognosis
30 results:
1. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
2. Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
Wu G; Wang Q; Wang D; Xiong F; Liu W; Chen J; Wang B; Huang W; Wang X; Chen Y
Clin Transl Med; 2023 Dec; 13(12):e1502. PubMed ID: 38050190
[TBL] [Abstract] [Full Text] [Related]
3. miR-137 Modulates Human Gastric cancer Cell Proliferation, Apoptosis, and Migration by Targeting ezh2.
Weng XQ; Wang W
Crit Rev Eukaryot Gene Expr; 2022; 32(4):31-40. PubMed ID: 35695663
[TBL] [Abstract] [Full Text] [Related]
4. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
[TBL] [Abstract] [Full Text] [Related]
5. SOX8 Affects Tumoral SPARC Expression by Regulating ezh2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC.
Yuan S; Xu J; Zhou B; Zhou Y; Lang M; Cao J; Liu Z; Yang S; Gao S; Hao J
Int J Biol Sci; 2022; 18(3):911-922. PubMed ID: 35173526
[TBL] [Abstract] [Full Text] [Related]
6. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/ezh2 complex in pancreatic cancer.
Sun Y; Ren D; Zhou Y; Shen J; Wu H; Jin X
Cell Death Dis; 2021 Sep; 12(10):878. PubMed ID: 34564701
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of ezh2.
Ye J; Fu Y; Wang Z; Yu J
Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456
[TBL] [Abstract] [Full Text] [Related]
8. A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients.
Liu Y; Liu X; Gu Y; Lu H
Medicine (Baltimore); 2021 Jul; 100(29):e26491. PubMed ID: 34398005
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression.
Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y
Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1.
Zhai S; Xu Z; Xie J; Zhang J; Wang X; Peng C; Li H; Chen H; Shen B; Deng X
Oncogene; 2021 Jan; 40(2):277-291. PubMed ID: 33122827
[TBL] [Abstract] [Full Text] [Related]
11. ezh2 Downregulation Augments the Effect of Irradiation in Reducing pancreatic cancer Cell Proliferation
Agrawal R; Chen M; Bukhari Z; Ogunwobi OO; Haseeb MA; Martello LA
Ann Clin Lab Sci; 2020 Jan; 50(1):45-56. PubMed ID: 32161011
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of long noncoding RNA SNHG14 suppresses cell proliferation and invasion by regulating ezh2 in pancreatic ductal adenocarcinoma (PDAC).
Xie F; Huang Q; Wang C; Chen S; Liu C; Lin X; Lv X; Wang C
Cancer Biomark; 2020; 27(3):357-364. PubMed ID: 31929143
[TBL] [Abstract] [Full Text] [Related]
13. ANLN-induced ezh2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract] [Full Text] [Related]
14. The Lncrna-TUG1/ezh2 Axis Promotes pancreatic cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract] [Full Text] [Related]
15. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice.
Chen S; Chen JZ; Zhang JQ; Chen HX; Yan ML; Huang L; Tian YF; Chen YL; Wang YD
Cancer Lett; 2016 Dec; 383(1):73-84. PubMed ID: 27693633
[TBL] [Abstract] [Full Text] [Related]
16. PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
[TBL] [Abstract] [Full Text] [Related]
17. ezh2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
[TBL] [Abstract] [Full Text] [Related]
18. A crucial epithelial to mesenchymal transition regulator, Sox4/ezh2 axis is closely related to the clinical outcome in pancreatic cancer patients.
Hasegawa S; Nagano H; Konno M; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Wada H; Hama N; Kawamoto K; Marubashi S; Nishida N; Koseki J; Mori M; Doki Y; Ishii H
Int J Oncol; 2016 Jan; 48(1):145-52. PubMed ID: 26648239
[TBL] [Abstract] [Full Text] [Related]
19. H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma.
Chen S; Chen J; Zhan Q; Zhu Y; Chen H; Deng X; Hou Z; Shen B; Chen Y; Peng C
Oncotarget; 2014 Nov; 5(21):10421-33. PubMed ID: 25431952
[TBL] [Abstract] [Full Text] [Related]
20. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an ezh2 dependent manner.
Zhang K; Sun X; Zhou X; Han L; Chen L; Shi Z; Zhang A; Ye M; Wang Q; Liu C; Wei J; Ren Y; Yang J; Zhang J; Pu P; Li M; Kang C
Oncotarget; 2015 Jan; 6(1):537-46. PubMed ID: 25428914
[TBL] [Abstract] [Full Text] [Related]
[Next]